Navigation Links
Actual use of asthma medications contradicts guidelines
Date:3/28/2008

A study has found only 16% of the 352,082 Australians who filled a prescription for asthma preventer medications for the first time during the period July 2004 to June 2005, went on to use them regularly.

Most (61%) first time users did not fill another prescription in the next two years while 22% did so sporadically.

The research will be presented at the Thoracic Society of Australia and New Zealand (TSANZ) Conference which starts this Sunday in Melbourne.

The study was conducted by the Australian Centre for Asthma Monitoring, a collaborating unit of the Australian Institute of Health and Welfare based at the Woolcock Institute of Medical Research in Sydney. It analysed the anonymous Pharmaceutical Benefits Scheme (PBS) records of individuals who filled a prescription for preventer medications for asthma for the first time between July 2004 and June 2005, and their subsequent prescription activity over a period of two years. The most commonly used form of preventer medication is inhaled corticosteroids.

Professor Guy Marks, Head of Epidemiology Research at the Woolcock Institute, said the results indicated that the prevalence of one-time and sporadic use was highest in young adults (age 15-34 years) with regular use most common in adults aged 65 years and over.

The PBS dataset is a valuable tool for assessing patterns of asthma medication use, he said.

Importantly this study shows that while guidelines recommend regular use of preventer medication, this certainly isnt happening in the community. At least some of those people who are now using preventer medication sporadically, could be expected to benefit from regular use of this class of medications.


'/>"/>

Contact: Lucy Williams
lucyw@woolcock.org.au
61-403-753-028
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Dr. Oz and Dr. Roizen Prove That Aging Is Actually Reversible in You: Staying Young on Discovery Health
2. More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints
3. FDA Probing Possible Link Between Asthma Drug and Suicide Risk
4. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
5. Asthma medicines often not prescribed as national guidelines recommend
6. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
7. NIH Asthma Guidelines Will Leave Sufferers Breathing Easier This Spring
8. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
9. Aspirin Reduces Asthma Risk Among Older Women
10. UniCare of West Virginia Providing Assistance for Asthma Education Training
11. Treatment for mild asthma leads to improved lung function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a ... Scooters . , Mobility Scooters give freedom to people who need help getting around. ... may be facing a long period of rehabilitation after an illness or accident. There ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is a ... lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO of ... create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... GA (PRWEB) , ... December ... ... technology and security executive networking and relationship-marketing firm, announced today that nominations ... the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education ... Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on ... “We are honored to have Amy E. Herman present at this year’s conference, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016   Lexicon Pharmaceuticals, ... results today from a Phase 2 clinical study of ... Lexicon in collaboration with JDRF, the leading global organization ... of this Phase 2 clinical trial, which randomized a ... of a once-daily 400 mg dose of sotagliflozin compared ...
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... PORTLAND, Oregon and PUNE, India ... a new report by Allied Market Research, titled, "Global Cancer ... the global revenue of cancer biomarkers market is projected to ... at a CAGR of 13.3% from 2016 to 2022. Omic ... share in 2015 and is expected to maintain its dominance ...
Breaking Medicine Technology: